Hyperfine (HYPR) said Tuesday it has agreed to sell about 4.5 million shares along with warrants to purchase up to approximately 4.5 million shares at a price of $1.33 per share-and-warrant pair in a registered direct offering.
The health technology company said gross proceeds are expected to total $6.0 million once the offering closes Wednesday.
Hyperfine said it plans to use net proceeds for working capital and general corporate purposes.
Shares of the company were down more than 14% in Tuesday's premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.